Bisphosphonates induce inflammation and rupture of atherosclerotic plaques in apolipoprotein-E null mice

Biochemical and Biophysical Research Communications

Volumn 328, Issue 3, 2005, Pages 790-793

  Shimshi, Mona ^a,b   Abe, Etsuko ^a   Fisher, Edward A ^a   Zaidi, Mone ^a   Fallon, John T ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Atherosclerosis; Drugs; Inflammation; Plaques; Thrombosis

Indexed keywords

ALENDRONIC ACID; APOLIPOPROTEIN E; BISPHOSPHONIC ACID DERIVATIVE; CASPASE 3; METALLOPROTEINASE; RISEDRONIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; BONE DENSITY; CONTROLLED STUDY; EVALUATION; FEEDING; FEMALE; IMMUNOCYTOCHEMISTRY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ANIMALIA;

EID: 13444291268     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.12.091     Document Type: Article

References (17)

1. H.J. Schluesener, and R. Meyermann Immunolocalization of BMP-6, a novel TGF-β-related cytokine, in normal and atherosclerotic smooth muscle cells Atherosclerosis 113 1995 153 156
2. C.R. Dhore, J.P.M. Cleutjens, E. Lutgens, K.B. Cleutjens, P.J. Kitslaar, J.H. Tordoir, H.M. Spronk, C. Vermeer, and M.J. Daemen Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques Arterioscler. Thromb. Vasc. Biol. 21 2001 1998 2003
3. N. Bucay, I. Sarosi, C.R. Dunstan, S. Morony, J. Tarpley, C. Capparelli, S. Scully, H.L. Tan, W. Xu, D.L. Lacey, W.J. Boyle, and W.S. Simonet Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification Genes Dev. 12 1998 1260 1268
4. T.M. Doherty, H. Uzui, L.A. Fitzpatrick, P.V. Tripathi, C.R. Dunstan, K. Asotra, and T.B. Rajavashisth Rationale for the role of osteoclast-like cells in arterial calcification FASEB J. 16 2002 577 582
5. N. Mody, Y. Tintut, and D. Radcliff Vascular calcification and its relation to bone calcification: possible underlying mechanism J. Nucl. Cardiol. 10 2003 177 183
6. L.L. Demer Vascular calcification and osteoporosis: inflammatory responses to oxidized lipids Int. J. Epidemiol. 31 2002 737 741
7. R. Yitalo Bisphosphonates and atherosclerosis Gen. Pharmacol. 35 2002 287 296
8. J.E. Fisher, G.A. Rodan, and A.A. Reska In vivo effects of bisphosphonates on the osteoclast mevalonate pathway Endocrinology 141 2000 4793 4796
9. S.I. McFarlane, R. Muniyappa, and R. Francisco Pleiotrophic effects of statins: lipid reduction and beyond J. Clin. Endocrinol. Metab. 87 2002 1451 1458
10. K.L. Tyson, J.L. Reynolds, R. McNair, Q. Zhang, P.L. Weissberg, and C.M. Shanahan Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification Arterioscler. Thromb. Vasc. Biol. 23 2003 489 494
11. R. Visse, and H. Nagase Matrix metalloproteinases and tissue inhibitors of metalloproteinases Circ. Res. 92 2003 827 839
12. J.F. Bukowsky, C.C. Dascher, and H. Das Alternate bisphosphonate targets and mechanisms of action Biochem. Biophys. Res. Commun. 328 2005 746 750
13. V. Kunzmann, E. Bauer, and J. Feurle Stimulation of γ/δT cells by aminobisphosphonates an in induction of antiplasma cell activity in multiple myeloma cells Blood 96 2000 384 392
14. M. Schoppet, K.T. Preissner, and L.C. Hofbauer Rank ligand and osteoprotegrin Arterioscler. Thromb. Vasc. Biol. 22 2002 549 553
15. V. Viereck, G. Emons, V. Lauck, K.H. Frosch, S. Blaschke, C. Grundker, and L.C. Hofbauer Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts Biochem. Biophys. Res. Commun. 291 2002 680 686
16. P. Cullen, R. Baetta, and S. Bellosta Rupture of the atherosclerotic plaque: does a good animal model exist? Arterioscler. Thromb. Vasc. Biol. 23 2003 535 542
17. J.L. Breslow Mouse models of atherosclerosis Science 272 1996 685 688